Tailored antiplatelet therapy in stent assisted coiling for unruptured aneurysms: a nationwide registry study
- Authors
- Koh, Jun Seok; Hwang, Gyojun; Park, Jung Cheol; Lee, Chang-Young; Chung, Joonho; Lee, Sang-Weon; Kwon, Hyon-Jo; Kim, Seong-Rim; Kang, Dong-Hun; Kwon, Soon Chan; Kim, Sung-Tae; Chang, Chul Hoon; Jang, Dong-Kyu; Choi, Jae Hyung; Kim, Young Woo; Kim, Bum-Tae; Shin, Byoung Gook; You, Seung Hoon; Chung, Seung Young; Ko, Junkyeung; Kim, Tae Gon; Yoon, Seok-Mann; Lee, Jong Young; Park, Hyun; Park, Jung Hyun; Cho, Jae-Hoon; Koo, Hae-Won; Sung, Jae Hoon; Rhee, Jinnie; Shin, Ho Gyun; KoNES Registry Investigators
- Issue Date
- Nov-2023
- Publisher
- BMJ Publishing Group
- Keywords
- Aneurysm; Stent
- Citation
- Journal of NeuroInterventional Surgery, v.15, no.11, pp 1095 - 1104
- Pages
- 10
- Journal Title
- Journal of NeuroInterventional Surgery
- Volume
- 15
- Number
- 11
- Start Page
- 1095
- End Page
- 1104
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22264
- DOI
- 10.1136/jnis-2022-019571
- ISSN
- 1759-8478
1759-8486
- Abstract
- BackgroundAntiplatelet therapy, where regimens are tailored based on platelet function testing, has been introduced into neurointerventional surgery. This nationwide registry study evaluated the effect and safety of tailored antiplatelet therapy in stent assisted coiling for unruptured aneurysms compared with conventional therapy using a standard regimen. MethodsThis study enrolled 1686 patients in 44 participating centers who received stent assisted coiling for unruptured aneurysms between January 1, 2019 and December 31, 2019. The standard regimen (aspirin and clopidogrel) was used for all patients in the conventional group (924, 19 centers). The regimen was selected based on platelet function testing (standard regimen for clopidogrel responders; adding cilostazol or replacing clopidogrel with other thienopyridines (ticlopidine, prasugrel, or ticagrelor) for clopidogrel non-responders) in the tailored group (762, 25 centers). The primary outcome was thromboembolic events. Secondary outcomes were bleeding and poor outcomes (increase in modified Rankin Scale score). Outcomes within 30 days after coiling were compared using logistic regression analysis. ResultsThe thromboembolic event rate was lower in the tailored group than in the conventional group (30/762 (3.9%) vs 63/924 (6.8%), adjusted OR 0.560, 95% CI 0.359 to 0.875, P=0.001). The bleeding event rate was not different between the study groups (62/762 (8.1%) vs 73/924 (7.9%), adjusted OR 0.790, 95% CI 0.469 to 1.331, P=0.376). Poor outcomes were less frequent in the tailored group (12/762 (1.6%) vs 34 (3.7%), adjusted OR 0.252, 95% CI 0.112 to 0.568, P=0.001). ConclusionTailored antiplatelet therapy in stent assisted coiling for unruptured aneurysms reduced thromboembolic events and poor outcomes without increasing bleeding.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Neurosurgery > 1. Journal Articles
- College of Medicine > Department of Neurosurgery > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.